Nuwellis, Inc. (NUWE)
Nasdaq · Healthcare · Medical Devices
$0.694+0.03%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $2.5M
- 52-week range
- $0.6827 – $172.90
- 52-week change
- −99.44%
- EPS (trailing)
- $437.18
- Next earnings
- Nov 11, 2026
Fiscal year to Dec 2025
- Revenue
- $8.3M (−5.38%)
- Net income
- −$17.5M
- Operating margin
- −134.3%
- Diluted EPS
- −$25.39
- Free cash flow
- −$10.9M
From the company’s annual report on SEC EDGAR.
About Nuwellis, Inc.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Headquarters: Eden Prairie, United States · 38 employees · nuwellis.com